Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Injections Although studies investigating BPC 157 have demonstrated therapeutic potential, most of these analyses have been performed in animal models
Group 1 received a saline injection as a control
If the solution appears cloudy, contains floating specks, or shows any color change, the vial may be compromised and should not be used
require documentation of indication, dosing, and clinical response Biologics (IL-12/23 inhibitor): Ustekinumab (Stelara, J3357) FDA-approved for moderate-to-severe CD
Full side-by-side
US$ 25.51
US$ 27.91
US$ 29.45
US$ 21.68
US$ 23.03
US$ 29.20
US$ 24.39
US$ 28.99
